BY | June 26, 2014

FDA acne drug alert WAARNNS of life threatening allergic reactions. FDA has asked people to try it first lightly before full use.

 

The Food and Drug Administration (FDA) has warned that the using certain acne treating products that contains the active ingredients benzoyl peroxide or salicylic acid can root unusual but severe and probably life-threatening allergic reactions or vicious irritation.

 

An active ingredient is the element that formulates the medicine efficient against the disease or condition it is treating. The acne products that are sold over-the-counter (OTC) and applied on the skin (topical) are to watch out for, warns FDA.

acne fda  warning

Serious allergic symptoms vary from the less risky irritations previously mentioned in the products’ Drug Facts labels that comprises of burning, dryness, itching, peeling, redness, and slight swelling where the medicine is applied.

 

“There is currently no mention of the possibility of these very severe allergic reactions on the product labels,” said Mona Khurana, M.D., a medical officer at FDA. “It’s important that consumers know about them, and that they know what to do if they occur.”

 

The products of apprehension are “Proactiv, Neutrogena, MaxClarity, Oxy, Ambi, Aveeno, Clean Clear, and store brands,” the FDA revealed. The products are offered as “gels, lotions, face washes, solutions, cleansing pads, toners, face scrubs, and other products.”

 

Those who experience any of the symptoms such as “throat tightness; difficulty breathing; feeling faint; or swelling of the eyes, face, lips, or tongue,” after applying the product then they should immediately stop using it, warns FDA.

 

“Before using an OTC topical acne drug product for the first time, apply a small amount to one or two small affected areas for 3 days to make sure you don’t develop any hypersensitivity symptoms. If no discomfort occurs, follow the directions on the Drug Facts label,” the FDA advised.

 

“FDA will continue to monitor closely and evaluate this safety issue,” Khurana said. The agency is also encouraging manufacturers to use the drug label to advise consumers how to test the product’s safety before using it for the first time.

 

FDA reported that it has released a Drug Safety Communication (DSC) to notify both consumers and health care professionals of the prospective hazards of such products.

RELATED

This is going to be an eye opener for millions of people across the world. Low-carb diet reduces body fat When fat accumulates in the body it gives trouble. And hence many doctors suggest a diet that is low on fat so as to avoid cardiovascular risks. For long the issues have...

This gives great hope to millions of people. New cholesterol-lowering pill manages 61% reduction in LDL-C Alirocumab is the talk of the medical fraternity. They are all praise for this pill and have touted it as an amazing cholesterol-lowering pill. The reason that it is...

Darapladib after ACS did not lower risk for patients in case of CHD death, MI and coronary revascularization Researchers after detailed study and research have concluded that Darapladib is of no benefit at all in ACS patients. Researchers say that people suffering from acute...

By Kareem Shaheen BEIRUT: How do you deal with sexual dysfunction or safe sex when even the mention of it at home is enough to elicit gasps of embarrassment and shock? Sandrine Atallah, a clinical sexologist, has some of the answers. The Lebanese doctor studied sexology...

sex issues in Lebanon

It is a sort of breakthrough. Novartis heart failure drug is best of its kind in a decade. It has been tested on 8k+ people This is going to be game changer when it comes to treating heart ailments. Many experts have said that this is one of the biggest breakthroughs in as...